They xpect positive sentiment towards the sector and further clinical success to maintain the share price at current levels. They have increased their price target to A$3.17 per share.
- Forums
- ASX - By Stock
- VCR
- abn research today
VCR
ventracor limited
abn research today
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)